• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Changing place, changing future: Repositioning a subcutaneous implantable cardioverter-defibrillator can resolve inappropriate shocks secondary to myopotential oversensing.

作者信息

Berne Paola, Viola Graziana, Motta Giovanni, Marziliano Nicola, Carboni Valerio, Casu Gavino

机构信息

Unità Operativa Complessa di Cardiologia, Ospedale San Francesco, Nuoro, Italy.

出版信息

HeartRhythm Case Rep. 2017 Aug 1;3(10):475-478. doi: 10.1016/j.hrcr.2017.07.009. eCollection 2017 Oct.

DOI:10.1016/j.hrcr.2017.07.009
PMID:29062701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5643850/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c0/5643850/0957ab6fdf68/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c0/5643850/45d58f1c4848/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c0/5643850/dec7b32482eb/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c0/5643850/0957ab6fdf68/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c0/5643850/45d58f1c4848/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c0/5643850/dec7b32482eb/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c0/5643850/0957ab6fdf68/gr3.jpg

相似文献

1
Changing place, changing future: Repositioning a subcutaneous implantable cardioverter-defibrillator can resolve inappropriate shocks secondary to myopotential oversensing.改变位置，改变未来：重新定位皮下植入式心脏复律除颤器可解决因肌电位过度感知导致的不适当电击问题。
HeartRhythm Case Rep. 2017 Aug 1;3(10):475-478. doi: 10.1016/j.hrcr.2017.07.009. eCollection 2017 Oct.
2
Subcutaneous Implantable Cardioverter Defibrillator Lead Repositioning for Preventing Inappropriate Shocks Due to Myopotential Oversensing in a Post-Fulminant Myocarditis Patient.皮下植入式心脏复律除颤器导线重新定位以预防暴发性心肌炎患者因肌电位过度感知导致的不适当电击
Int Heart J. 2019 Mar 20;60(2):466-469. doi: 10.1536/ihj.18-324. Epub 2019 Feb 8.
3
Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.儿茶酚胺能多形性室性心动过速的除颤治疗结果
Heart Rhythm. 2014 Jan;11(1):58-66. doi: 10.1016/j.hrthm.2013.10.027. Epub 2013 Oct 11.
4
Inappropriate Shock Due to Myopotential Oversensing in a Patient With Subcutaneous Implantable Cardioverter-Defibrillator.
Heart Lung Circ. 2019 Apr;28(4):e88-e90. doi: 10.1016/j.hlc.2018.08.030. Epub 2018 Oct 11.
5
Incidence of myopotential induction in subcutaneous implantable cardioverter-defibrillator patients: Is the oversensing issue really solved?皮下植入式心律转复除颤器患者的肌电位感应发生率：过感知问题真的解决了吗？
Heart Rhythm. 2019 Oct;16(10):1523-1530. doi: 10.1016/j.hrthm.2019.04.044. Epub 2019 Jun 7.
6
Oversensing issues leading to device extraction: When subcutaneous implantable cardioverter-defibrillator reached a dead-end.导致设备取出的感知过度问题：当皮下植入式心律转复除颤器走到尽头时。
Heart Rhythm. 2020 Jan;17(1):66-74. doi: 10.1016/j.hrthm.2019.07.004. Epub 2019 Jul 8.
7
Myopotential Oversensing Is a Major Cause of Inappropriate Shock in Subcutaneous Implantable Defibrillator in Japan.肌电位过度感知是日本皮下植入式除颤器不适当电击的主要原因。
Int Heart J. 2020 Sep 29;61(5):913-921. doi: 10.1536/ihj.20-129. Epub 2020 Sep 12.
8
Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.根据电击节律对植入式心脏复律除颤器和心脏再同步治疗除颤器受者电击治疗后的生存情况。节律研究中的 ALTITUDE 生存情况。
J Am Coll Cardiol. 2013 Oct 29;62(18):1674-1679. doi: 10.1016/j.jacc.2013.04.083. Epub 2013 Jun 27.
9
Surface electromyography of myopotential oversensing provoked by simultaneous straining and leftward twisting in a patient with an implantable cardioverter defibrillator.一名植入式心脏复律除颤器患者在同时用力和向左扭转时引发肌电位过度感知的表面肌电图。
Heart Vessels. 2017 Mar;32(3):364-368. doi: 10.1007/s00380-016-0888-9. Epub 2016 Aug 30.
10
Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?皮下植入式心律转复除颤器电击：恰当还是不恰当？
J Innov Card Rhythm Manag. 2017 May 15;8(5):2728-2731. doi: 10.19102/icrm.2017.080504. eCollection 2017 May.

引用本文的文献

1
Management of sensing issues with a subcutaneous implantable cardioverter-defibrillator in a patient with Brugada syndrome: A case report.布加综合征患者皮下植入式心律转复除颤器感知问题的管理：一例报告
HeartRhythm Case Rep. 2023 Sep 16;9(12):878-882. doi: 10.1016/j.hrcr.2023.09.009. eCollection 2023 Dec.
2
Pooled Analysis of Complications with Transvenous ICD Compared to Subcutaneous ICD in Patients with Catecholaminergic Polymorphic Ventricular Arrhythmia.儿茶酚胺能多形性室性心律失常患者经静脉植入式心律转复除颤器与皮下植入式心律转复除颤器并发症的汇总分析。
J Pers Med. 2022 Mar 28;12(4):536. doi: 10.3390/jpm12040536.
3

本文引用的文献

1
2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs.2015 年欧洲心脏病学会关于心室性心律失常患者管理和心源性猝死预防指南概要，由共同主席总结。
Eur Heart J. 2015 Nov 1;36(41):2757-9. doi: 10.1093/eurheartj/ehv445.
2
Analyses of inappropriate shocks in a Spanish ICD primary prevention population: Predictors and prognoses.西班牙植入式心律转复除颤器（ICD）一级预防人群中不适当电击的分析：预测因素和预后
Int J Cardiol. 2015 Sep 15;195:188-94. doi: 10.1016/j.ijcard.2015.05.146. Epub 2015 May 29.
3
Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management.
Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience.
皮下植入式心律转复除颤器在致心律失常性右室心肌病/发育不良患者中的应用：一项跨大西洋经验。
J Am Heart Assoc. 2018 Nov 6;7(21):e008782. doi: 10.1161/JAHA.118.008782.
皮下植入式心律转复除颤器（ICD）的不适当电击：发生率、预测因素及处理
Int J Cardiol. 2015 Sep 15;195:126-33. doi: 10.1016/j.ijcard.2015.05.135. Epub 2015 May 22.
4
Inappropriate shock for myopotential over-sensing in a patient with subcutaneous ICD.皮下植入式心律转复除颤器（ICD）患者因肌电位过度感知而不适当电击。
Indian Heart J. 2015 Jan-Feb;67(1):56-9. doi: 10.1016/j.ihj.2015.01.001. Epub 2015 Feb 12.
5
Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry.全球完全皮下植入式除颤器的经验：来自EFFORTLESS S-ICD注册研究的早期结果。
Eur Heart J. 2014 Jul 1;35(25):1657-65. doi: 10.1093/eurheartj/ehu112. Epub 2014 Mar 26.
6
Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.儿茶酚胺能多形性室性心动过速的除颤治疗结果
Heart Rhythm. 2014 Jan;11(1):58-66. doi: 10.1016/j.hrthm.2013.10.027. Epub 2013 Oct 11.
7
Current evidence base for use of the implantable cardioverter-defibrillator.植入式心脏复律除颤器使用的当前证据基础。
Circulation. 2013 Jul 9;128(2):172-83. doi: 10.1161/CIRCULATIONAHA.112.000547.
8
Noise, artifact, and oversensing related inappropriate ICD shock evaluation: ALTITUDE noise study.噪声、伪迹及感知过度相关的不适当植入式心律转复除颤器电击评估：海拔高度噪声研究
Pacing Clin Electrophysiol. 2012 Jul;35(7):863-9. doi: 10.1111/j.1540-8159.2012.03407.x. Epub 2012 Apr 22.
9
Real world evaluation of dual-zone ICD and CRT-D programming compared to single-zone programming: the ALTITUDE REDUCES study.双区 ICD 和 CRT-D 编程与单区编程的真实世界评估：ALTITUDE REDUCES 研究。
J Cardiovasc Electrophysiol. 2011 Sep;22(9):1023-9. doi: 10.1111/j.1540-8167.2011.02086.x. Epub 2011 May 31.
10
Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome.Brugada综合征患者原发性预防性植入式心律转复除颤器治疗的长期随访
Eur Heart J. 2007 Feb;28(3):334-44. doi: 10.1093/eurheartj/ehl450. Epub 2007 Jan 24.